Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

Drugmakers now ‘masters’ at rolling out their own generics to stifle competition

When PDL BioPharma's $40 million blood-pressure medicine faced the threat of a generic rival this year, the company pulled out a little-known strategy that critics say helps keep drugs expensive and competition weak.

5 Aug 2019

California bill would fight deals that delay generic drugs

California's attorney general touted a legal victory this week against drugmakers who he said made secretive, backroom deals to keep less expensive drugs off the market.

1 Aug 2019

Summer setbacks: The long road to lower drug prices hits some potholes

When Washington returned from its winter holiday break in January, it seemed everyone was talking about lowering drug prices.

24 Jul 2019

Medicare recipients may pay more for generics than their brand-name counterparts, study finds

Medicare Part D enrollees may pay more out of pocket for high-priced specialty generic drugs than their brand-name counterparts, according to new research by health policy experts at Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill.

2 Jul 2019

Summer bummer: A young camper’s $142,938 snakebite

It was dusk as Oakley Yoder and the other summer camp kids hiked back to their tents at Illinois' Jackson Falls last July. As the group approached a mound of boulders blocking the path, Oakley, then 9, didn't see the lurking snake — until it bit a toe on her right foot.

30 Apr 2019

Klobuchar wants to stop ‘pay-for-delay’ deals that keep drug prices high

Washington's recent fixation with lowering drug costs has introduced Americans to once-insider terms like "pharmacy benefit managers" and "list prices."

26 Apr 2019

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose.

22 Apr 2019

Mulvaney: Trump brought down drug prices for the first time in 50 years

President Donald Trump announced last month that the GOP will become “the party of health care,” and news reports suggest he intends to make it a top issue in his reelection campaign.

15 Apr 2019

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices.

7 Feb 2019

FDA approves first generic version of commonly prescribed asthma inhaler

The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

30 Jan 2019

Trump zeroes in on surprise medical bills in White House chat with patients, experts

President Donald Trump on Wednesday instructed administration officials to investigate how to prevent surprise medical bills, broadening his focus on drug prices to include other issues of price transparency in health care.

23 Jan 2019

Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives

University at Buffalo researchers received an $880,000 grant to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices

21 Jan 2019

FDA approves generic drug for treating focal seizures

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.

16 Jan 2019

Research shows link between higher generic drug use and Medicare Part D star ratings

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that Medicare Part D prescription plans with higher generic drug use have higher summary star ratings and improved member experience.

25 Oct 2018

Mayo Clinic collaborates with seven hospitals to establish not-for-profit generic drug company

Mayo Clinic joins a coalition of seven hospitals in launching Civica Rx, a not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications. The company, which is organized as a Delaware nonstock, not-for-profit corporation, will be headquartered in Utah.

7 Sep 2018

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

Generic Drug News and Research

Further Reading

Drugmakers now ‘masters’ at rolling out their own generics to stifle competition

California bill would fight deals that delay generic drugs

Summer setbacks: The long road to lower drug prices hits some potholes

Medicare recipients may pay more for generics than their brand-name counterparts, study finds

Summer bummer: A young camper’s $142,938 snakebite

Klobuchar wants to stop ‘pay-for-delay’ deals that keep drug prices high

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

Mulvaney: Trump brought down drug prices for the first time in 50 years

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

FDA approves first generic version of commonly prescribed asthma inhaler

Trump zeroes in on surprise medical bills in White House chat with patients, experts

Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives

FDA approves generic drug for treating focal seizures

Research shows link between higher generic drug use and Medicare Part D star ratings

Mayo Clinic collaborates with seven hospitals to establish not-for-profit generic drug company

FDA grants approval for first generic version of epinephrine auto-injector

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

Medicaid expansion making diabetes meds more accessible to poor, study shows

To tame prescription prices, HHS dips a toe into drug importation stream

Study introduces novel strategy to obtain reasonable drug cost estimates for cost-effectiveness analyses

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News